Live Breaking News & Updates on Investors General

Stay updated with breaking news from Investors general. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Aelis Farma: Combined General Meeting of June 4, 2024: Availability of Preparatory Documents and Participation and Voting Procedures

Aelis Farma: Combined General Meeting of June 4, 2024: Availability of Preparatory Documents and Participation and Voting Procedures
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Neurocentre Magendie , Arthur Rouill , Daelis Farma , Vincenzo Piazza , Corporate Development , Regulatory News , Combined General Meeting , Lafaurie De Mondabon , General Meeting , Investors General , Commercial Code , Pier Vincenzo Piazza , Down Syndrome , Euronext Paris , Universal Registration Document , Des March , Corporate Development Officer , Oresansky Aur , Chance Des ,

Aelis Farma: Combined General Meeting of May 24, 2023: Availability of Preparatory Documents and Participation and Voting Procedures

Aelis Farma (ISIN: FR0014007ZB4 Ticker: AELIS, PEA-PME eligible) (Paris: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases, informs ....

United States , France General , Vincenzo Piazza , Magendie Neurocenter , Daelis Farma , Arthur Rouill , Combined General Meeting , Lafaurie De Mondabon , General Meeting , Investors General , Commercial Code , Signaling Specific , Pier Vincenzo Piazza , Down Syndrome , Euronext Paris , Universal Registration Document , Des March ,

Aelis Farma: Ordinary General Meeting of June 28, 2022: Availability of Preparatory Documents and Participation and Voting Procedures

Regulatory News: Aelis Farma (ISIN code: FR0014007ZB4 ticker: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases (the Company »), ....

United States , Nicolas Merigeau , Vincenzo Piazza , Inserm Magendie Neurocentre , Daelis Farma , Albert Marquet , Inserm Transfert Initiative , Centre Broca Nouvelle Aquitaine , Neurology Of The French Academy Sciences , Regulatory News , Ordinary General Meeting , General Meeting , Investors General , Commercial Code , Signaling Specific , Pier Vincenzo Piazza , Grand Prix , French Academy , Nouvelle Aquitaine Region , Euronext Paris , Marine De Fages ,

Transgene's Combined General Meeting of May 25, 2022

Regulatory News: The Combined Ordinary and Extraordinary General Meeting of Transgene's (Paris:TNG) shareholders was held today (May 25, 2022) at 10:00 a.m. at the Company's headquarters (400 boulevard ....

United States , Illkirch Graffenstaden , Rheinland Pfalz , Lucie Larguier , Sandrine Flory , Ben Brahim , Alessandro Riva , Marie Landel , Sylvie Berrebi , Laurence Espinasse , Philippe Archinard , Transgene Euronext , Centre Sud Montpellier , European Society Of Medical Oncology , European Commission Conticanet , Claude Bernard University In Lyon , French National Cancer Institute , Scientific Panel For Health , French National Academy Of Medicine , European Organization For Research , Cell Gene Therapy At Gilead Sciences , Global Head Of Oncology Development , Ichnos Sciences , Ernst Young , Corporate Communications , Affairs At Novartis Pharmaceuticals ,

Genomic Vision Announces the Approval by Its Shareholders' Meeting of All the Resolutions Supported by the Executive Board

Regulatory News: Genomic Vision(FR0011799907 GV the "Company"), a biotechnology company that develops tools and services dedicated to the analysis and control of changes in the genome, informs its ....

France General , Dominique Remy Renou , Strategic Communications , Regulatory News , Extraordinary Shareholder Meeting , Des Meuniers , Investors General , Genomic Vision ,